MediFind
Condition

Adult T-Cell Leukemia

Condition 101

What is the definition of Adult T-Cell Leukemia?

Adult T-cell leukemia/lymphoma (ATL) is is a rare and aggressive T-cell lymphoma that is linked to infection by the human T-cell lymphotropic virus 1 (HTLV-1). The exact mechanism by which HTLV-I infection causes the ATL is unknown. The clinical features of ATL include generalized swel ...

For more information, visit GARD

What are the alternative names for Adult T-Cell Leukemia?

  • ATLL
  • Adult T-cell leukaemia
  • Adult T-cell leukaemia/lymphoma (HTLV-1 positive)
  • Adult T-cell lymphoma

Latest Research

Latest Advance
Study
  • Condition: Adults with Tuberculosis/HIV
  • Journal: The New England journal of medicine
  • Treatment Used: Systematic vs Test-Guided Treatment
  • Number of Patients: 522
  • Published —
This study compared the effectiveness of systematic (treatment that targets the entire body) versus test-guided treatment for adults with tuberculosis (infectious disease that mainly affects the lungs) and HIV (virus that attacks the body’s immune system).
Latest Advance
Study
  • Condition: COVID-19 with Severe Systemic Hyperinflammation
  • Journal: Leukemia
  • Treatment Used: Ruxolitinib
  • Number of Patients: 105
  • Published —
This study tested the safety and efficacy of using ruxolitinib to treat patients with COVID-19 with severe systemic hyperinflammation.
Latest Advance
Study
  • Condition: Lymphoma and Leukemia
  • Journal: Critical reviews in oncology/hematology
  • Treatment Used: Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
  • Number of Patients: 0
  • Published —
This article updates information on chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of lymphoma and leukemia.
Latest Advance
Study
  • Condition: T-Cell Acute Lymphoblastic Leukemia
  • Journal: Cancer medicine
  • Treatment Used: Cytarabine, Aclarubicin, and G-csf Regimen
  • Number of Patients: 41
  • Published —
In this study, researchers evaluated the outcomes of using the cytarabine, aclarubicin, and G-CSF regimen for the treatment of T-cell acute lymphoblastic leukemia.